Oncology
Conference Coverage
Combo shows promise for checkpoint inhibitor-refractory urothelial carcinoma
NATIONAL HARBOR, MD – Combination sitravatinib and nivolumab produced responses in patients with checkpoint...
Latest News
Small nodules, big problems: AI's role in thyroid nodule diagnosis
A novel algorithm for benign thyroid nodules showed good sensitivity and specificity.
News
Postcolonoscopy colorectal cancers had unique features
Their predisposition to the proximal colon and to microsatellite instability suggests that they have unique characteristics of tumorigenesis.
Conference Coverage
In Oregon, ‘war on melanoma’ takes flight
LAS VEGAS – Research project hopes to shrink melanoma mortality by emphasizing education, screening.
Conference Coverage
Better overall survival with nivolumab vs. chemo for advanced ESCC
BARCELONA –Nivolumab was associated with improved overall survival and a favorable safety profile vs. chemotherapy...
Conference Coverage
Melanoma incidence continues to increase, yet mortality stabilizing
LAS VEGAS –Targeted screening efforts that stratify by risk factors and by age “makes screening more efficient and more cost effective.”
News
Though metastatic breast cancer survival is improving, rates vary by region
A lag in survival improvement across different regions suggests that some groups and regions may benefit unequally from treatment advances as well...
News
ACP: Low-risk adults aged 50-75 should undergo regular screening for colorectal cancer
New guidance statement says the best test is the one that patients and clinicians agree fits individual need.
Latest News
More evidence that statins reduce HCC risk
SAN ANTONIO – Largest-ever meta-analysis shows 43% relative risk reduction in HCC.
Latest News
Levothyroxine dose for checkpoint inhibitor toxicity may be too high
CHICAGO – Dosing need not be automatically boosted when starting checkpoint inhibitor therapy.
